Viewing Study NCT01502592


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2025-12-25 @ 5:02 PM
Study NCT ID: NCT01502592
Status: COMPLETED
Last Update Posted: 2016-01-05
First Post: 2011-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module